Publications by Professor Matthew Collin - ePrints

Browsing publications by Professor Matthew Collin.

Newcastle Authors	Title	Year
Professor Matthew Collin	Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party study	2024
Professor Matthew Collin	Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation – a registry study on behalf of the EBMT Acute Leukemia Working Party	2024
Professor Matthew Collin	Incidence and outcome of central nervous system relapse after hematopoietic stem cell transplantation in patients suffering from acute myeloid leukemia and acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation	2024
Dr Simon Bomken Professor Matthew Collin	Langerhans cell histiocytosis: NACHO update on progress, chaos, and opportunity on the path to rational cures	2024
Professor Matthew Collin	Risk factors for Nocardia infection among allogeneic hematopoietic cell transplant recipients: A case-control study of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation	2024
Professor Matthew Collin	Autologous hematopoietic cell transplantation (autoHCT) for T-cell/histiocyte-rich large B-cell lymphoma (THRLBCL): An EBMT Lymphoma Working Party study	2023
Professor Matthew Collin	Histiocytes set on the heart: cardiac complications of Erdheim-Chester disease	2023
Professor Matthew Collin	Histiocytic neoplasms: Going, going, but not quite gone	2023
Dr Callum Wright Dr Clare Lendrem Dr Amy Publicover Louise Duncan Dr Venetia Bigley et al.	Host versus graft HLA-DP1 mismatching promotes graft versus host disease	2023
Dr Paul Milne Dr Simon Bomken Maymoon Madkhali Jamie Macdonald Dr Preeti Singh et al.	Lineage switching of the cellular distribution of BRAFV600E in multisystem Langerhans cell histiocytosis	2023
Professor Matthew Collin	National advisory panels for childhood cancer in the United Kingdom: An evaluation of current practice and a best practice statement for the future	2023
Professor Matthew Collin	Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases	2023
Professor Matthew Collin	Reading the Ts and DCs of thymopoiesis	2023
Dr Alex Blain Dr Christopher Bacon Professor Vikki Rand Professor Matthew Collin Dr Christopher Carey et al.	Spatial and molecular profiling of the mononuclear phagocyte network in classic Hodgkin lymphoma	2023
Imogen Franklin Dr Paul Milne Jordan Childs Dr Roisin Boggan Isabel Barrow et al.	T cell differentiation drives the negative selection of pathogenic mitochondrial DNA variants	2023
Professor Matthew Collin Professor Andrew Gennery	Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT	2022
Dr Wei-yu Lin Dr Sarah Fordham Dr Nicola Sunter Dr Claire Elstob Dr Yaobo Xu et al.	Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia (Nature Communications, (2021), 12, 1, (6233), 10.1038/s41467-021-26551-x)	2022
Dr Ricky Tirtakusuma Dr Katarzyna Szoltysek Professor Vasily Grinev Dr Sirintra Nakjang Dr Daniel Williamson et al.	Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia	2022
Professor Matthew Collin	International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults	2022
Dr Paul Milne Dr Anastasia Resteu Professor Matthew Collin	Notch-dependent cooperativity between myeloid lineages promotes Langerhans cell histiocytosis pathology	2022
Professor Matthew Collin	Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation	2022
Dr Paul Milne Professor Matthew Collin	Divergent clonal evolution of blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia from a shared TET2-mutated origin	2021
Professor Matthew Collin	FLT3 ligand in acute myeloid leukemia: a simple test with deep implications	2021
Dr Preeti Singh Maninder Heer Dr Anastasia Resteu Dr Aneta Mikulasova Dr Mojgan Reza et al.	GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1	2021
Dr Wei-Yu Lin Dr Sarah Fordham Dr Nicola Sunter Dr Claire Elstob Dr Yaobo Xu et al.	Genome-wide association study identifies susceptibility loci for acute myeloid leukemia	2021
Professor Matthew Collin	Histiocytic disorders	2021
Professor Matthew Collin	Histiocytosis	2021
Professor Matthew Collin	Long-term outcome of patients receiving haematopoietic allogeneic stem cell transplantation as first transplant for high-risk Hodgkin lymphoma: a retrospective analysis from the Lymphoma Working Party-EBMT	2021
Professor Matthew Collin Dr Venetia Bigley	Many Langerhans make light work of skin immunity	2021
Dr Paul Milne Dr Anastasia Resteu Professor Matthew Collin	Notch-Mediated Generation of Monocyte-Derived Langerhans Cells: Phenotype and Function	2021
Dr Rachel Crossland Jean Norden Dr Kim Pearce Dr Clare Lendrem Professor Matthew Collin et al.	Profiling Tissue and Biofluid miR-155-5p,miR-155* and miR-146a-5p Expression in Graft vs Host Disease	2021
Professor Matthew Collin	Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT	2021
Trevor Liddle Dr Ina Schim van der Loeff Dr Ken Baker Dr Christopher Duncan Dr Aidan Hanrath et al.	COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study	2020
Dr Urszula Cytlak-Chaudhuri Dr Anastasia Resteu Sarah Pagan Dr Kile Green Dr Paul Milne et al.	Differential IRF8 Transcription Factor Requirement Defines Two Pathways of Dendritic Cell Development in Humans	2020
Dr Laura Jardine Dr Urszula Cytlak-Chaudhuri Dr Merry Gunawan Dr Gary Reynolds Dr Kile Green et al.	Donor monocyte-derived macrophages promote human acute graft-versus-host disease	2020
Professor Matthew Collin	Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era	2020
Dr Venetia Bigley Professor Matthew Collin	Insights from Patients with Dendritic Cell Immunodeficiency	2020
Professor Matthew Collin	Peripheral host T cells survive hematopoietic stem cell transplantation and promote graft-versus-host disease	2020
Professor Matthew Collin Kirsty Thomson	Reducing the diversity of allogeneic transplant protocols in the UK through a BSBMT Anthony Nolan Protocol Harmonization Initiative	2020
Dr Preeti Singh Professor Matthew Collin	Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency	2020
Professor Matthew Collin	EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)	2019
Dr Venetia Bigley Dr Urszula Cytlak-Chaudhuri Professor Matthew Collin	Human dendritic cell immunodeficiencies	2019
Professor Matthew Collin	Human dendritic cells	2019
Dr Laura Jardine Dr Sarah Wiscombe Dr Gary Reynolds Dr David McDonald Andrew Fuller et al.	Lipopolysaccharide inhalation recruits monocytes and dendritic cell subsets to the alveolar airspace.	2019
Dr Paul Milne Dr Venetia Bigley Dr Amy Publicover Sarah Pagan Dr Helen Marr et al.	Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia	2019
Professor Matthew Collin	The coming of age of Langerhans cell histiocytosis	2019
Dr Katherine Sturgess Dr Rachel Dickinson Professor Andrew Gennery Professor Andrew Cant Professor Graham Jackson et al.	In vivo T-depleted reduced intensity transplantation for GATA2-related immune dysfunction.	2018
Dr Venetia Bigley Dr Urszula Cytlak-Chaudhuri Dr Laura Jardine Dr Kile Green Dr Merry Gunawan et al.	Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation	2018
Professor Matthew Collin	Death, eaters, and dark marks	2018
Sadaf Atarod Jean Norden Louis Bibby Dr Clare Lendrem Dr Kim Pearce et al.	Differential MicroRNA Expression Levels in Cutaneous Acute Graft-versus-Host Disease	2018
Professor Matthew Collin Dr Venetia Bigley	Human dendritic cell subsets: an update	2018
Dr Xiao Wang Professor Matthew Collin	Hyaluronan Receptor LYVE-1-Expressing Macrophages Maintain Arterial Tone through Hyaluronan-Mediated Regulation of Smooth Muscle Cell Collagen	2018
Dr Urszula Cytlak-Chaudhuri Dr Anastasia Resteu Dr Tom Altmann Professor Andrew Gennery Professor Graham Jackson et al.	Ikaros family zinc finger 1 regulates dendritic cell development and function in humans	2018
Dr Urszula Cytlak-Chaudhuri Dr Anastasia Resteu Professor Matthew Collin Dr Venetia Bigley	Notch signaling facilitates in vitro generation of cross-presenting classical dendritic cells	2018
Jean Norden Dr Kim Pearce Professor Julie Irving Professor Matthew Collin Professor Anne Dickinson et al.	The influence of glucocorticoid receptor single nucleotide polymorphisms on outcome after haematopoietic stem cell transplantation	2018
Professor Matthew Collin	Tumour genesis syndrome in relapsed B lymphoblastic leukaemia	2018
Dr Venetia Bigley Dr Rachel Dickinson Professor Matthew Collin	Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells	2017
Professor Matthew Collin	Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMT	2017
Dr Venetia Bigley Professor Matthew Collin Professor Andrew Cant	Biallelic mutations in IRF8 impair human NK cell maturation and function	2017
Professor Matthew Collin	GATA2 deficiency and related myeloid neoplasms	2017
Dr Paul Milne Dr Venetia Bigley Dr Christopher Bacon Dr Naomi McGovern Dr Simon Bomken et al.	Hematopoietic origin of Langerhans cell histiocytosis and Erdheim Chester disease in adults	2017
Dr Naomi McGovern Dr Xiao Wang Dr Venetia Bigley Professor Matthew Collin Professor Muzlifah Haniffa et al.	Human fetal dendritic cells promote prenatal T-cell immune suppression through arginase-2	2017
Professor Matthew Collin	I am SAMD9L: 7q regulator I am	2017
Margherita Boieri Dr Clare Lendrem Professor Matthew Collin Professor Anne Dickinson	IL-12, IL-15, and IL-18 pre-activated NK cells target resistant T cell acute lymphoblastic leukemia and delay leukemia development in vivo	2017
Dr Kile Green Dr Kim Pearce Dr Laura Jardine Dr Venetia Bigley Professor Graham Jackson et al.	Impact of Alemtuzumab Scheduling on Graft-versus-Host Disease after Unrelated Donor Fludarabine and Melphalan Allografts	2017
Professor Matthew Collin	Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation	2017
Dr Rachel Crossland Jean Norden Dr Kim Pearce Dr Clare Lendrem Louis Bibby et al.	Serum and Extracellular Vesicle MicroRNAs miR-423, miR-199, and miR-93* As Biomarkers for Acute Graft-versus-Host Disease	2017
Dr Paul Milne Dr Venetia Bigley Professor Matthew Collin	Targeted treatment of brainstem neurohistiocytosis guided by urinary cell-free DNA	2017
Dr Venetia Bigley Professor Matthew Collin	Dendritic cell analysis in primary immunodeficiency	2016
Professor Matthew Collin Professor Muzlifah Haniffa	Dendritic Cells and Dendritic Cell Subsets	2016
Dr Tom Creasey Dr Gail Jones Professor Matthew Collin	Granulocyte infusion: benefit beyond neutrophils?	2016
Dr Shaheda Ahmed Dr Xiao Wang Jean Norden Dr Kim Pearce Dr Ebtesam El-Gezawy et al.	Identification and validation of biomarkers associated with acute and chronic graft versus host disease [Corrigendum]	2016
Professor Matthew Collin	Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci	2016
Professor Matthew Collin Dr Paul Milne	Langerhans cell origin and regulation	2016
Sadaf Atarod Ahmed Ahmed Dr Clare Lendrem Dr Kim Pearce Dr Wei Cope et al.	MiR-146a and miR-155 expression levels in acute graft-versus-host disease incidence	2016
Professor Matthew Collin Dr Venetia Bigley	Monocyte, macrophage, and dendritic cell development: The human perspective	2016
Dr Venetia Bigley Dr Simon Bomken Professor Matthew Collin	National Web-Based Meetings Help to Identify Histiocytosis Patients with Refractory Disease or Sequelae who Need Individualised or Novel Treatment Strategies	2016
Dr Venetia Bigley Professor Matthew Collin	Single-gene association between GATA-2 and autoimmune hepatitis: A novel genetic insight highlighting immunologic pathways to disease	2016
Professor Matthew Collin Dr Paul Milne Dr Venetia Bigley Professor Muzlifah Haniffa	The Hematopoietic Origin of Adult Histiocytosis	2016
Professor Matthew Collin	The Mononuclear Phagocyte System in Organ Transplantation	2016
Dr Sara Mannurita Dr Venetia Bigley Professor Matthew Collin Dr Eleonora Gambineri	Timely follow-up of a GATA2 deficiency patient allows successful treatment	2016
Dr Gary Reynolds Dr Paul Milne Dr Venetia Bigley Professor Matthew Collin Professor John Isaacs et al.	Use of the dendritic cell marker, B and T lymphocyte attenuator, to identify functionally distinct subsets of human CD1c+ dendritic cells	2016
Dr Laura Jardine Dr Venetia Bigley Dr Kim Pearce Dr Alison Dickinson Professor Graham Jackson et al.	A comparative study of reduced dose alemtuzumab in matched unrelated donor and related donor reduced intensity transplants	2015
Dr Jane Salotti Dr Venetia Bigley Dr Katrina Wood Professor Matthew Collin Dr Kevin Windebank et al.	A Regional Study of Adults with Histiocytic Disorders in Northeast England	2015
Professor Matthew Collin Professor Patrick Chinnery	Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy	2015
Dr Venetia Bigley Professor Matthew Collin	Autoimmune hepatitis with T-regulatory cell deficiency in the context of GATA-2 dysfunction: A novel single gene association	2015
Dr Paul Milne Dr Venetia Bigley Dr Merry Gunawan Professor Muzlifah Haniffa Professor Matthew Collin et al.	CD1c⁺ blood dendritic cells have Langerhans cell potential	2015
Professor Matthew Collin Dr Venetia Bigley	Cell(s) of Origin of Langerhans Cell Histiocytosis	2015
Dr Lindsay Nicholson Professor Matthew Collin Professor Anne Dickinson Dr Xiao Wang	Developing an in vitro predictive test for steroid response in graft versus host disease	2015
Dr Lindsay Nicholson Professor Matthew Collin Professor Anne Dickinson Dr Xiao Wang	Developing an in vitro predictive test for steroid response in graft versus host disease	2015
Gladys - Dr Kim Pearce Jean Norden Dr Clare Lendrem Dr Rachel Crossland et al.	Differential microRNA expressions in cutaneous acute graft-versus-host disease	2015
Sadaf Atarod Brie Turner Dr Kim Pearce Dr Shaheda Ahmed Jean Norden et al.	Elevated level of HSPA1L mRNA correlates with graft-versus-host disease	2015
Professor Matthew Collin Dr Rachel Dickinson Dr Venetia Bigley	Haematopoietic and immune defects associated with GATA2 mutation	2015
Professor Muzlifah Haniffa Dr Venetia Bigley Professor Matthew Collin	Human mononuclear phagocyte system reunited	2015
Dr Shaheda Ahmed Dr Xiao Wang Jean Norden Dr Kim Pearce Dr Ebtesam El-Gezawy et al.	Identification and validation of biomarkers associated with acute and chronic graft versus host disease	2015
Dr Venetia Bigley Dr Naomi McGovern Dr Paul Milne Dr Rachel Dickinson Sarah Pagan et al.	Langerin-expressing dendritic cells in human tissues are related to CD1c⁺ dendritic cells and distinct from Langerhans cells and CD₁₄₁^high XCR1⁺ dendritic cells	2015
Dr Paul Milne Professor Matthew Collin Dr Venetia Bigley Dr Christopher Bacon Dr Naomi McGovern et al.	Mapping the BRAFV600E Hematopoietic Clone of Adult Multi-System Langerhans Cell Histiocytosis	2015
Sadaf Atarod Dr Clare Lendrem Dr Kim Pearce Jean Norden Professor Matthew Collin et al.	MiR-146a and miR-155 expression levels in allogeneic haematopoietic stem cell transplantation patients is predictive of acute graft-versus-host incidence	2015
Dr Kim Pearce Jean Norden Professor Matthew Collin Professor Graham Jackson Dr Udo Holtick et al.	Predicting survival using clinical risk score and non-HLA immunogenetics	2015
Dr Rachel Crossland Jean Norden Louis Bibby Professor Matthew Collin Professor Anne Dickinson et al.	Serum MicroRNAs MiR-146a, MiR-199, MiR-93*and MiR-423 as Biomarkers for Graft Versus Host Disease	2015
Professor Matthew Collin Dr Paul Milne Dr Venetia Bigley Professor Muzlifah Haniffa	Studies on the Pathway of Differentiation of LCH Cells	2015
Dr Rachel Crossland Jean Norden Professor Matthew Collin Professor Anne Dickinson	Urinary MicroRNA Expression is Associated with Incidence and Severity of Graft Versus Host Disease	2015
Professor Matthew Collin Dr Laura Jardine	A question of persistence: Langerhans cells and graft-versus-host disease	2014
Dr Xiao Wang Dr Naomi McGovern Dr Merry Gunawan Dr Connor Richardson Professor Matthew Collin et al.	A Three Dimensional Atlas of Human Dermal Leukocytes, Lymphatics and Blood Vessels	2014
Dr Jane Salotti Dr Venetia Bigley Professor Matthew Collin	An Epidemiological Survey of Adults with Histiocytic Disorders in the Northeast Region of the UK	2014
Professor Matthew Collin Dr William Howell	An Extra HLA Hapotype in Peripheral Blood: Cells Acquired from a Sibling in Utero	2014
Dr Venetia Bigley Professor Matthew Collin	BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups	2014
Dr Paul Milne Dr Venetia Bigley Dr Merry Gunawan Professor Muzlifah Haniffa Professor Matthew Collin et al.	CD1c+ blood dendritic cells have Langerhans cell potential	2014
Dr Xiao Wang Dr Christopher Bacon Alison Long Sarah Pagan Professor Matthew Collin et al.	Factor XIIIa identifies macrophages and cells of mesenchymal origin in the human skin	2014
Dr Naomi McGovern Dr Merry Gunawan Dr Laura Jardine Dr Elizabeth Poyner Kile Green et al.	Human Dermal CD14⁺ Cells Are a Transient Population of Monocyte-Derived Macrophages	2014
Dr Venetia Bigley Dr Rachel Dickinson Dr Laura Jardine Dr Paul Milne Dr Helen Griffin et al.	Human SHP-1 Mutation Causes an Autoinflammatory and Immunodeficiency Phenotype	2014
Dr Naomi McGovern Dr Merry Gunawan Dr Laura Jardine Dr Elizabeth Poyner Dr Kile Green et al.	Human tissue mononuclear phagocyte system revisited	2014
Professor Matthew Collin	Langerhans Cell Homeostasis and Turnover After Nonmyeloablative and Myeloablative Allogeneic Hematopoietic Cell Transplantation	2014
Dr Lucy Walker Dr Paul Milne Professor Matthew Collin	Lectin-like Transcript 1 in Germinal Centres	2014
Dr Xiao Wang Dr Naomi McGovern Dr Merry Gunawan Dr Connor Richardson Professor Matthew Collin et al.	Microanatomical dissection of the human dermis: the three-dimensional relationship between leucocytes, lymphatics and blood vessels	2014
Professor Anne Dickinson Professor Matthew Collin	Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation	2014
Dr Rachel Dickinson Dr Paul Milne Sarah Pagan Dr Venetia Bigley Professor Matthew Collin et al.	Reduced GATA-2 expression in individuals with DCML deficiency	2014
Dr Laura Jardine Dr Kile Green Professor Graham Jackson Professor Matthew Collin	Synergy of Unrelated Donor and Full Intensity Conditioning Breaks the Control of Graft Versus Host Disease By Alemtuzumab	2014
Professor Graham Jackson Dr Venetia Bigley Professor Matthew Collin	T cell depleted reduced intensity transplantation is effective for patients with GATA2 mutation and severe infections or respiratory compromise	2014
Dr Rachel Dickinson Paul Milne Dr Laura Jardine Dr Naomi McGovern Dr Sharon Cookson et al.	The evolution of cellular deficiency in GATA2 mutation	2014
Dr Lindsay Nicholson Professor Matthew Collin Professor Anne Dickinson Dr Xiao Wang	Treg Induced Impairment of DC Function and Its Impact on GvH Reactions	2014
Dr Rachel Crossland Jean Norden Professor Matthew Collin Professor Anne Dickinson	Urinary Micrornas MiR-377, MiR-423, MiR-93 and MiR-199 As Biomarkers for Graft Versus Host Disease	2014
Dr Kile Green Dr Laura Jardine Dr Kim Pearce Dr Venetia Bigley Professor Graham Jackson et al.	Defining The Optimal Dose Of Alemtuzumab In Unrelated Donor Reduced Intensity Allografts: A UK Retrospective Study	2013
Dr Kim Pearce Dr Shaheda Ahmed Jean Norden Professor Matthew Collin Dr Xiao Wang et al.	Genomic risk factors and biomarkers as predictors of GvHD after haematopoietic stem cell transplantation	2013
Professor Matthew Collin Dr Naomi McGovern Professor Muzlifah Haniffa	Human dendritic cell subsets	2013
Dr Naomi McGovern Dr Laura Jardine Harriet Purvis Professor Catharien Hilkens Professor Matthew Collin et al.	IRF4 Transcription Factor-Dependent CD11b⁺ Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine Responses	2013
Dr Naomi McGovern Dr Kevin Windebank Sarah Pagan Dr Venetia Bigley Professor Matthew Collin et al.	Microanatomical dissection of the human dermis: The relationship between antigen presenting cells, lymphatic and blood vessels	2013
Sadaf Atarod Dr Wei Cope Jean Norden Professor Matthew Collin	MiR-146a-5p and its targets in graft-versus-host disease	2013
Professor Matthew Collin	Monocytes, macrophages, and dendritic cells	2013
Dr Laura Jardine Ashley Ames-Draycott Sarah Pagan Dr Sharon Cookson Dr Gavin Spickett et al.	Rapid detection of dendritic cell and monocyte disorders using CD4 as a lineage marker of the human peripheral blood antigen-presenting cell compartment	2013
Dr Laura Jardine Professor Sophie Hambleton Dr Venetia Bigley Sarah Pagan Dr Xiao Wang et al.	Sensitizing primary acute lymphoblastic leukemia to natural killer cell recognition by induction of NKG2D ligands	2013
Dr Eleonora Gambineri Dr Sara Mannurita Dr Venetia Bigley Professor Matthew Collin	Timely Follow-up of a GATA2 Deficiency Patient as Predictor of Successful Treatment	2013
Dr Kevin Windebank Dr Venetia Bigley Professor Muzlifah Haniffa Professor Matthew Collin	Treatment of Adult LCH with Subcutaneous Cladribine	2013
Dr Thomas Huegle Dr Steven O'Reilly Rachel Simpson Dr Venetia Bigley Professor Matthew Collin et al.	Tumor Necrosis Factor-Costimulated T Lymphocytes From Patients With Systemic Sclerosis Trigger Collagen Production in Fibroblasts	2013
Professor Anne Dickinson Professor Matthew Collin	Urinary proteomic peptide profiling allows preemptive diagnosis of acute graft-versus-host-disease after allogeneic stem cell transplantation	2013
Dr Emily Mavin Sadaf Atarod Professor Matthew Collin Professor Anne Dickinson Dr Xiao Wang et al.	An association between skin homing T-cells and graft-versus-host disease	2012
Dr Stamatina Verykiou Dr Naomi McGovern Paul Milne Professor Matthew Collin Professor Muzlifah Haniffa et al.	Enhancing diagnostic sensitivity for cutaneous blastic plasmacytoid dendritic cell neoplasia	2012
Professor Matthew Collin Dr Rachel Dickinson Professor Muzlifah Haniffa Dr Naomi McGovern Dr Helen Griffin et al.	Evolution of Dendritic Cell, Monocyte B and NK Lymphoid (DCML) deficiency; a human primary immunodeficiency arising from GATA-2 mutation	2012
Sadaf Atarod Brie Turner Jean Norden Professor Matthew Collin Professor Anne Dickinson et al.	HSPA1L and HSPA1B mRNA expression in the pathogenesis of graft-versus-host disease	2012
Dr Venetia Bigley Dr Rachel Dickinson Professor Andrew Gennery Dr Helen Griffin Professor Muzlifah Haniffa et al.	Human dendritic cell deficiency	2012
Professor Muzlifah Haniffa Dr Venetia Bigley Dr Naomi McGovern Dr Xiao Wang Sarah Pagan et al.	Human Tissues Contain CD141^hiCross-Presenting Dendritic Cells with Functional Homology to Mouse CD103⁺ Nonlymphoid Dendritic Cells	2012
Professor Muzlifah Haniffa Dr Venetia Bigley Dr Naomi McGovern Dr Xiao Wang Professor Matthew Collin et al.	Identification of a novel cross-presenting migratory dendritic cell in the human skin: the key cell for rational vaccine strategies	2012
Dr Naomi McGovern Dr Rachel Dickinson Dr Venetia Bigley Professor Matthew Collin	Identification of GATA-2 mutations using a simple screening procedure in patients with Papilloma virus infections	2012
Professor Muzlifah Haniffa Dr Venetia Bigley Dr Naomi McGovern Dr Xiao Wang Professor Matthew Collin et al.	Identification of the human cross-presenting migratory dendritic cell	2012
Professor Muzlifah Haniffa Dr Venetia Bigley Dr Naomi McGovern Professor Matthew Collin	Identification of the human cross-presenting migratory dendritic cell and harmonization of the functional classification of human and mouse dendritic cells	2012
Dr Catherine Stroud Professor Matthew Collin Professor Graham Jackson Dr Terence Flood Dr John Mansfield et al.	Idiopathic colitis following haematopoietic stem cell transplantation for chronic granulomatous disease: Three cases at a national centre	2012
Sadaf Atarod Dr Wei Cope Jean Norden Professor Matthew Collin Professor Anne Dickinson et al.	miR-146a expression in graft-versus-host disease	2012
Dr Jonathan Lane Professor Mary Slatter Professor Sophie Hambleton Dr Terence Flood Professor Andrew Cant et al.	Outcome of haematopoietic stem cell transplantation in patients with chronic granulomatous disease at a national centre	2012
Dr Katherine Sturgess Professor Mary Slatter Dr Venetia Bigley Dr Rachel Dickinson Professor Muzlifah Haniffa et al.	Reduced-intensity haematopoietic stem cell transplant rescues immune function and corrects pulmonary alveolar proteinosis in DCML deficiency/GATA 2 mutation	2012
Dr Emily Mavin Dr Shaheda Ahmed Dr Graeme O'Boyle Brie Turner Stephen Douglass et al.	Regulatory T Cells Inhibit CD8+ T-Cell Tissue Invasion in Human Skin Graft-Versus-Host Reactions	2012
Sadaf Atarod Dr Wei Cope Jean Norden Professor Matthew Collin Professor Anne Dickinson et al.	Role of miR-146a-5p in Graft-versus-Host Disease	2012
Dr Steven O'Reilly Dr Venetia Bigley Professor Matthew Collin Dr Anja Krippner-Heidenreich Professor Jaap van Laar et al.	Tumor necrosis factor-alpha co-activated T-cells support a profibrotic cytokine milieu on cost of IL-10 expression in patients with systemic sclerosis	2012
Professor Sophie Hambleton Dr Venetia Bigley Professor Muzlifah Haniffa Dr Christopher Bacon Professor Andrew Cant et al.	IRF8 Mutations and Human Dendritic-Cell Immunodeficiency	2011
Xiaomeng Wang Brie Turner Dr Graeme O'Boyle Dr Saeed Ahmed Dr Emily Mavin et al.	Blocking effector T-cell trafficking contributes to regulatory T-cell mediated suppression of GvHD reactions	2011
Professor Muzlifah Haniffa Dr Venetia Bigley Dr Naomi McGovern Dr Xiao Wang Hongwei Zhou et al.	CD141(+) human migratory dendritic cells are homologous to murine CD103+dendritic cells and excel at exogenous antigen cross-presentation	2011
Sadaf Atarod Jean Norden Anna Kuzyk-Czucha Brie Turner Lyndsy Ambler et al.	Correlation of HSPA1Lexpression with the development of graft-versus-host disease	2011
Dr Venetia Bigley Professor Matthew Collin	Dendritic cell, monocyte, B and NK lymphoid deficiency defines the lost lineages of a new GATA-2 dependent myelodysplastic syndrome	2011
Dr Venetia Bigley Professor Muzlifah Haniffa Dr Xiao Wang Dr Rachel Dickinson Dr Naomi McGovern et al.	Dendritic cell, monocyte, B and NK lymphoid deficiency: a novel but potentially fatal haematological disorder curable with haematopoietic stem cell transplantation	2011
Dr Kim Pearce Jean Norden Professor Matthew Collin Dr Udo Holtick Professor Anne Dickinson et al.	Development of an algorithm to predict acute GvHD and chronic GvHD in HLA-matched sibling, non-T cell depleted haematopoietic stem cell transplants	2011
Dr Rachel Dickinson Dr Helen Griffin Dr Venetia Bigley Dr Louise Reynard Raf Hussain et al.	Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency	2011
Dr Samuel Moses Professor Matthew Collin Dr Daniela Lee Brid Crowley	Extensive oral herpes simplex virus type 1 infection in a haematopoietic stem cell transplant recipient not responding to aciclovir	2011
Dr Rachel Dickinson Dr Venetia Bigley Dr Helen Griffin Professor Jeremy Lakey Dr Naomi McGovern et al.	Human dendritic cell deficiency is caused by GATA-2 mutation	2011
Professor Matthew Collin Dr Venetia Bigley Professor Muzlifah Haniffa Professor Sophie Hambleton	Human dendritic cell deficiency: the missing ID?	2011
Dr Naomi McGovern Dr Venetia Bigley Professor Muzlifah Haniffa Dr Xiao Wang Dr Rachel Dickinson et al.	Human Langerin plus dendritic cells are independent of epithelial Langerhans cells; a novel perspective on Langerhans cell histiocytosis	2011
Jean Norden Professor Matthew Collin Professor Graham Jackson Professor Anne Dickinson	Prognostic Significance of Interleukin-7 Receptor-alpha Gene Polymorphisms in Allogeneic Stem-Cell Transplantation: A Confirmatory Study	2011
Dr Katherine Sturgess Professor Mary Slatter Dr Venetia Bigley Professor Muzlifah Haniffa Dr Xiao Wang et al.	Reduced Intensity Hematopoietic Stem Cell Transplant Rescues Immune Function and Corrects Pulmonary Alveolar Proteinosis in DCML Deficiency/GATA 2 Mutation	2011
Dr Venetia Bigley Dr Xiao Wang Dr Rachel Dickinson Dr Naomi McGovern Sarah Pagan et al.	The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency	2011
Dr Thomas Huegle Dr Anja Krippner-Heidenreich Rachel Simpson Dr Steven O'Reilly Dr Venetia Bigley et al.	Tumour necrosis factor alpha receptor activated T cells of patients with systemic sclerosis are deficient in IL-10 expression but promote myofibroblast differentiation via IL-6 and TGF-beta	2011
Dr Michelle Rae Dr Xiao Wang Professor Matthew Collin Professor Anne Dickinson	A preliminary investigation into the kinetics of MSC induced immuno-modulation during the allo-reactive phase of an MLR	2010
Dr Wei Cope Dr Laura Jardine Dr Venetia Bigley Sarah Pagan Brie Turner et al.	A retrospective study of alemtuzumab level, t-cell chimerism and graft-versus-host disease using intermediate dose alemtuzumab for matched related and matched unrelated reduced-intensity transplantation	2010
Professor Graham Jackson Professor Matthew Collin Jean Norden	Clinical and genetic risk assessment for overall survival in haematopoietic stem cell transplantation	2010
Professor Muzlifah Haniffa Professor Matthew Collin	Comparison of gene expression profiles between human and mouse monocyte subsets	2010
Professor Muzlifah Haniffa Professor Matthew Collin	Comparison of gene expression profiles between human and mouse monocyte subsets (Blood (2010) 115, 3 (e10-e19))	2010
Dr Venetia Bigley Dr Laura Jardine Professor Matthew Collin	Connecting the dots: monocyte/DC and NK subsets in human peripheral blood	2010
Professor Matthew Collin	Impact of in vivo alemtuzumab dose before reduced intensity conditioning and HLA-identical sibling stem cell transplantation: pharmacokinetics, GVHD, and immune reconstitution	2010
Dr Venetia Bigley Dr Clare Morgan Professor Matthew Collin Dr James Lordan	Pulmonary alveolar proteinosis due to monocytopenia: lung transplant or haematopoeitic stem cell transplant? [abstract]	2010
Brie Turner Professor Matthew Collin	Reduced intensity conditioning for hematopoietic stem cell transplantation: has it achieved all it set out to?	2010
Dr Rachel Dickinson Dr Venetia Bigley Professor Matthew Collin	The Equilibration of Peripheral Blood and Tissue CD3+T Cell Engraftment Is Influenced by Graft Versus Host Disease Following Reduced Intensity Conditioning Stem Cell Transplantation.	2010
Professor Muzlifah Haniffa Dr Venetia Bigley Sarah Pagan Dr Xiao Wang Professor Matthew Collin et al.	The persistence of recipient antigen presenting cells after stem cell transplantation in humans	2010
Professor Anne Dickinson Professor Matthew Collin	"ATG16 L1 a Additional Risk Factor for TRM After allogeneic Stem Cell Transplantation"	2009
Dr Venetia Bigley Sarah Pagan Brie Turner Professor Graham Jackson Professor Anne Dickinson et al.	A Retrospective Study of Alemtuzumab Level, T Cell Chimerism and Graft Versus Host Disease Using Intermediate Dose Alemtuzumab for Matched Related and Matched Unrelated Reduced Intensity Transplantation.	2009
Dr Roger Pearce Professor Matthew Collin	Alemtuzumab markedly reduces chronic GVHD without affecting overall survival in reduced-intensity conditioning sibling allo-SCT for adults with AML	2009
Professor Anne Dickinson Dr Kim Pearce Professor Graham Jackson Professor Matthew Collin Jean Norden et al.	Clinical and Genetic Risk Assessment for Overall Survival in Haematopoietic Stem Cell Transplantation (HSCT)	2009
Professor Muzlifah Haniffa Dr Xiao Wang Dr Venetia Bigley Ian Dimmick Dr Trevor Booth et al.	Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantation	2009
Dr Laura Jardine Professor Sophie Hambleton Dr Venetia Bigley Sarah Pagan Professor Matthew Collin et al.	Drug-Induced, NKG2D-Dependent Sensitization of ALL Cell Lines to NK Recognition	2009
Professor Matthew Collin Dr Venetia Bigley Professor Muzlifah Haniffa Dr Kevin Windebank	Langerin Plus Dermal Dendritic Cells: Closer to Langerhans Cell Histiocytosis than Langerhans Cells?	2009
Professor Muzlifah Haniffa Professor Matthew Collin	Mesenchymal stem cells: The fibroblasts' new clothes?	2009
Brie Turner Dr Shaheda Ahmed Sarah Pagan Jean Norden Professor Matthew Collin et al.	Regulatory T Cells Prevent Effector T Cell Infiltration Into GvHD Target Tissue by Affecting Chemokine Signaling	2009
Dr Xiao Wang Dr Udo Holtick Professor Matthew Collin Professor Graham Jackson Professor Catharien Hilkens et al.	Regulatory T-Cell Suppression of CD8⁺ T-Cell-Mediated Graft-Versus-Host Reaction Requires Their Presence During Priming	2009
Dr Xiao Wang Suzanne Alshemali Professor Matthew Collin	Differential homeostasis and function of human dermal macrophages and dendritic cells: implications for the induction of graft versus host responses	2008
Dr Terence Flood Dr Gavin Spickett Professor Graham Jackson Professor Matthew Collin Dr Mario Abinun et al.	Haematopoeitic stem cell transplantation for chronic granulomatous disease - a single-centre experience	2008
Professor Muzlifah Haniffa Suzanne Alshemali Professor Matthew Collin	Human factor XIIIa+ melanophages outlive all other cutaneous antigen-presenting cells, including Langerhans cells, after haematopoietic transplantation	2008
Professor Matthew Collin	Immunization with a lentivector that targets tumor antigen expression to dendritic cells induces potent CD8+ and CD4+ T-cell responses	2008
Professor Matthew Collin	Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells	2008
Dr Karen Wallace Professor Muzlifah Haniffa Professor Matthew Collin Professor Matthew Wright	Skin Derived Fibroblasts Can Differentiate Into Hepatocyte-Like Cells	2008
Dr Udo Holtick Jean Norden Professor Anne Dickinson Professor Matthew Collin	The TLR adapter Mal/TIRAP protein variant leu 180 influences graft-versus-leukaemia and graft-versus-host reactions after allogeneic haematopoietic stem cell transplantation	2008
Professor Muzlifah Haniffa Dr Xiao Wang Dr Udo Holtick Dr Michelle Rae Professor John Isaacs et al.	Adult Human Fibroblasts Are Potent Immunoregulatory Cells and Functionally Equivalent to Mesenchymal Stem Cells	2007
Professor Andrew Gennery Professor Matthew Collin	Follow up in the first year after hemopoietic stem cell transplantation	2007
Dr Udo Holtick Dr Scott Marshall Professor Stephen O'Brien Professor Matthew Collin	Potent graft-versus-leukemia effect in BCR/ABL negative chronic myelogenous leukemia	2007
Dr Udo Holtick Professor Anne Dickinson Dr Peter Middleton Professor Matthew Collin	Impact of mismatching CD1a, a dimorphic antigen-presenting molecule, on graft-versus-host disease after hematopoietic stem cell transplantation	2006
Dr Scott Marshall Professor Matthew Collin Professor Anne Dickinson	Phase II prospective study of extracorporeal phototherapy for the treatment of refractory chronic extensive graft-versus-host disease performed in Newcastle Upon Tyne	2006
Dr Xiao Wang Professor Matthew Collin Professor Graham Jackson Professor Anne Dickinson	Skin Explant Model of Human Graft-Versus-Host Disease: Prediction of Clinical Outcome and Correlation with Biological Risk Factors	2006
Professor Matthew Collin Professor Graham Jackson Dr Jennifer Cavet Dr Peter Middleton Professor Anne Dickinson et al.	The fate of human Langerhans cells in hematopoietic stem cell transplantation	2006
Dr Udo Holtick Dr Peter Middleton Jane Harrold Professor Anne Dickinson Professor Matthew Collin et al.	The MyD88 adapter-like (Mal) protein variant Leu 180, a candidate polymorphism for protection against graft versus host disease	2006
Professor Matthew Collin Dr Xiao Wang Professor Anne Dickinson	In vitro depletion of tissue-derived dendritic cells by CMRF-44 antibody and alemtuzumab: Implications for the control of graft-versus-host disease	2005
Professor Matthew Collin Dr Trevor Booth Professor Anne Dickinson	The effect of conditioning therapy on Langerhans' cell density in human bone marrow transplantation	2004
Professor Matthew Collin Dr Xiao Wang Professor Anne Dickinson	Antibody-mediated suppression of allogeneic responses by targeting the tissue dendritic cell: A potential role for CMRF-44 where alemtuzumab fails	2003
Dr Richard Bellamy Professor Matthew Collin David Wilkinson	Genetic susceptibility to tuberculosis in Africans: a genome-wide scan	2000
Professor Matthew Collin	Drug interactions, renal impairment and hypoglycaemia in a patient with Type II diabetes	1999